Cannell Capital - XILIO THERAPEUTICS INC ownership

XILIO THERAPEUTICS INC's ticker is and the CUSIP is 98422T100. A total of 33 filers reported holding XILIO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Cannell Capital ownership history of XILIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$53,969
+17.8%
17,0250.0%0.01%
+11.1%
Q4 2022$45,797
-8.4%
17,0250.0%0.01%
-18.2%
Q3 2022$50,000
+284.6%
17,025
+274.6%
0.01%
+266.7%
Q2 2022$13,0004,5450.00%
Other shareholders
XILIO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
RiverVest Venture Management LLC 1,441,444$3,041,4477.52%
Trustees of Columbia University in the City of New York 249,635$526,7300.97%
Atlas Venture Life Science Advisors, LLC 2,759,344$5,822,2160.90%
Octagon Capital Advisors LP 2,318,500$4,892,0350.75%
Bain Capital Life Sciences Investors, LLC 2,805,413$5,919,4210.66%
HARVARD MANAGEMENT CO INC 416,059$8780.10%
Rock Springs Capital Management LP 1,440,759$3,040,0010.08%
Soleus Capital Management, L.P. 226,941$478,8460.04%
Artal Group S.A. 450,000$9500.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 110,481$233,1150.01%
View complete list of XILIO THERAPEUTICS INC shareholders